Travel by plane: the puzzle of diabetics

By air, the new safety conditions prohibit the transport of liquid in the cabin. This measure becomes problematic for diabetics, when their treatment relies on insulin injections.

Towards the end of harassment?

No liquid in the cabin, does this mean that the insulin-treated diabetic patient must leave his medicines in these checked-in luggage?

Faced with this situation, the French Association of Diabetics (AFD) requested in September 2007 a joint meeting of all the parties concerned (the Directorate General of Civil Aviation - DGAC, airlines, airports and manufacturers Of insulin), to clarify this Kafkaesque situation.

In early November, a first meeting at the end of October 2007 with the DGAC suggests a quick solution. This meeting made it possible to specify several points concerning the transport of insulin by airplane as well as the obligations and rights of the diabetic traveler The DGAC confirms that the passengers with diabetes can carry in hand luggage the necessary insulin for the duration Of the flight and the following few days, without being limited to the quantity of this medicinal product necessary for flight time alone.

To the attention of the many diabetic travelers, obliged to present medical certificates and attestations various and dated, the DGAC reassured the AFD of the rule in this area, which must be applied by all: an order in French on behalf of the patient And valid is sufficient. It must include all the elements of the treatment carried during the trip (needles, pens injectors ...). On the other hand, if the passenger encounters difficulties when passing to the security station, he / she may call on the supervisor or the head of the security team.

It was finally agreed that a guide for diabetics to take the plane would be carried out by the AFD and validated by the DGAC. The AFD will distribute this guide to the diabetic population and to the DGAC to all its partners (companies, airports, travel agencies). So that traveling remains a freedom in safety for the 500 000 diabetics insulinotraités in the United States.

Communiqué of the French Diabetic Association - November 2007

First problem: carriers absolutely can not guarantee that they themselves, or the airport of embarkation will not misplace luggage and thus deprive the diabetic passenger of his treatment. Is further complicated when it can be read in all the records of insulin manufacturers that they formally prohibit the transport of insulin in the bunker ...

The DGAC recalls that "drugs are exempted from regulation" and confirms that a person with diabetes can not be prohibited from transporting the insulin required for his treatment as hand luggage for a period of several days; In the event of loss of luggage, it is essential that the diabetic person has his or her vital insulin treatment (and the equipment needed to monitor blood glucose) on him for a sufficient period of time that allows him Necessary to find a medical alternative after its arrival; Regulation is therefore explicit, but for AFD, the problem is based above all on "its application on a daily basis". The DGAC is therefore sending a clear message to industry professionals who are sometimes insufficiently informed about this new regulation.